We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OIG CITES TENS OF MILLIONS IN POTENTIAL DRUG REBATE BILLINGS
OIG CITES TENS OF MILLIONS IN POTENTIAL DRUG REBATE BILLINGS
April 27, 2004
Drugmakers could have to fork over another $37 million a year or more in Medicaid drug rebates if states take the advice of the HHS Office of Inspector General (OIG) and start billing manufacturers for rebates on physician-administered drugs.